Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Cencora Inc. chart...

About the Company

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.

CEO

Steven Collis

Exchange

NEW YORK STOCK EXCHANGE INC.

Website

https://www.amerisourcebergen.com/

$272B

Total Revenue

12K

Employees

$49B

Market Capitalization

26.88

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $COR News

Reasons to Add Cencora (COR) Stock in Your Portfolio Now

1d ago, source: Zacks.com on MSN

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

Cencora CEO Steven Collis to retire; company names successor

16d ago, source:

The global wholesale pharmaceutical company is getting just its third CEO since it was created through a $7 billion merger in ...

Walgreens Tightens Outlook While Beating Quarterly Estimates

on MSN ago, source:

Walgreens Boots Alliance Inc. narrowed its fiscal 2024 guidance even as the drugstore chain beat Wall Street’s estimates for ...

Insider Sell: Cencora Inc (COR) Chairman, President & CEO Steven Collis Sells 10,755 Shares

6d ago, source:

Steven Collis, Chairman, President & CEO of Cencora Inc (NYSE:COR), has sold 10,755 shares of the company on March 19, 2024, ...

Cencora (COR) Hits 52-Week High: What's Driving the Stock?

9d ago, source: Zacks.com on MSN

Shares of Cencora, Inc. COR scaled a new 52-week high of $240.86 on Mar 18, 2024, before closing the session slightly lower ...

Cencora Remains Chronically Undervalued, With Material Growth Potential

3d ago, source:

Cencora (formerly AmerisourceBergen) achieves strong financial growth, aiming to be a healthcare infrastructure leader. Find ...

Walgreens tightens outlook as shoppers cut back spending

5h ago, source:

Consumers are spending less on nonessential items and seeking more affordable options, Chief Financial Officer Manmohan Mahajan said on a call with investors.

Executive Vice President Elizabeth Campbell Sells Shares of Cencora Inc (COR)

7d ago, source:

Executive Vice President Elizabeth Campbell has sold 6,977 shares of Cencora Inc (NYSE:COR) on March 18, 2024, according to a ...

Walgreens dips after warning 'challenging' economy could dent bottom line

6h ago, source: Seeking Alpha on MSN

The tighter EPS guidance range was said to reflect a challenging retail environment in the U.S., the early wind-down of ...

Walgreens Boots Alliance (WBA) Shows Resilience in Q2 with $37.1 B in Sales

10h ago, source: The Tokenist

Walgreens Boots Alliance demonstrated resilience and adaptability in its fiscal Q2, with a 6.3 percent increase in sales.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...